This session brings together experts from various fields to address challenging cases in intestinal diseases, showcasing collaborative efforts to find solutions. We are excited to engage in the intriguing and enjoyable task of tackling complex issues in the treatment of challenging conditions.

KASID has been providing high-quality, evidence-based guidelines for intestinal diseases. In this session, we will present the latest guidelines for the diagnosis and treatment of Clostridioides difficile infection, along with the development process. In addition, this session will deal with the history and health-care contributions of KASID's guidelines.

- Prize: USD 200
- Number of winners: 50 Awardees
- Eligibility

• Pre-registration by March 31 (Sun.), 2024 is required.
• Participants of foreign affiliations who are not presenting authors can be candidates for the travel grants. Specifically, foreign participants who did not submit abstracts OR who are corresponding authors or co-authors are eligible.
• Participants from countries listed on the <DAC List of ODA Recipients by OECD> have priority, however, this qualification is only a priority, not mandatory.

IMKASID 2024 Pre-Registration is ongoing! We implore you to register now to take advantage of pre-registration rates and then join the IMKASID 2024!
Some sessions require pre-registration, so don't miss this opportunity.